Q32 Bio doses first subject in Bempikibart proof-of-concept study
Zura BIo collaborates with Benaroya Research Institute on immune disorder research
Flagship Pioneering names new senior partner and chief business development officer
FDA grants Orphan Drug Designation to Cantargia's CAN10 for systemic sclerosis treatment
MIRA Pharmaceuticals forms strategic partnership with MZ Group
Axcella granted patent for Long COVID fatigue treatment
AbbVie seeks regulatory approvals for SKYRIZI (risankizumab)to treat ulcerative colitis
Lynk Pharmaceuticals announces positive topline data from LNK01001 Phase II clinical trial
Formosa Pharmaceuticals signs licensing agreement with Eyenovia